Abstract:Qiong Tang, Dai Gong, Xiao-Min Ye, Jun-Ru Xu, Yi-Can Yang, Li-Juan Yan, Li Zou, Xiang-Lan Wen Department of Children Health Care Center, Zhuzhou Hospital Affiliated to Xiangya Medical College, Central South University, Zhuzhou, People's Republic of China Correspondence: Xiang-Lan Wen, Department of Children Health Care Center, Zhuzhou Hospital Affiliated to Xiangya Medical College, Central South University, No. 116 of Changjiang South Road, Tianyuan District, Zhuzhou City, Hunan Province, 412007, People's Republic of China, Tel +86 13873317331, Email Craniofacial dysmorphism, cardiac abnormalities, ectodermal abnormalities, psychomotor delay, intellectual disability, and short stature are all hallmarks of the extremely rare disorder known as cardiofaciocutaneous syndrome (CFCS). Although CFCS is considered rare, approximately 300 cases have been documented in the literature. In this report, we discuss a patient diagnosed with CFCS without the typical heart malformations but with craniofacial features, skin abnormalities, intellectual disability, and short stature. Genetic testing revealed the presence of three potentially harmful variants: one in the MAP2K1 gene and two in the ATP2B3 and CDC42BPB genes, the significance of which is currently not yet found. Our findings in this case report suggest that the clinical symptoms of CFCS may be atypical, thereby expanding our understanding of the symptom spectrum of the disease. Simultaneously, the link between the clinical symptoms of the patient and the two unknown pathogenic variants has not been established. This case report supplements existing clinical reference material by providing valuable insights into the specific scenario. Keywords: cardiofaciocutaneous syndrome, gene detection, intellectual disability, neurodevelopmental syndrome, short stature, spinocerebellar ataxia Cardiofaciocutaneous syndrome (CFCS) is an autosomal-dominant genetic disease of the renin-angiotensin system (RAS) cardiomyopathy group. This syndrome refers to a group of developmental disorders caused by the germline pathogenic variant of gene encoding RAS/Mitogen-activated protein kinase (MAPK) signaling pathway protein, and the pathogenic variant of four genes related to CFCS. These are BRAF (7q34), MAP2K1 (15q22.31), MAP2K2 (19p13.3, CFCS4, OMIM#615280), and KRAS (12p12.1), which encode the RAS protein (KRAS) and/or its downstream signals serine-threonine kinase ( BRAF, MEK1, MEK22 ). Among these, heterozygous pathogenic variants of BRAF gene are the most common, while MAP2K1, MAP2K2C2 , and KRAS genes are less involved. RAS cardiomyopathies include a wide variety of conditions, including Noonan syndrome (NS) and Costello syndrome (CS). 1–3 Therefore, CFCS is similar to NS and CS while also having its own unique characteristics. The clinical phenotypes of CFCS include craniofacial features, cardiac anomalies (most commonly atrial septal defect and pulmonary artery stenosis), hair and skin abnormalities, gastrointestinal dysfunction, neurocognitive delay, epilepsy, short stature, and slow weight gain. In addition, some patients lack immunoglobulins but exhibit no symptoms. 4 ATP2B3 and CDC42BPB play a key role in numerous cellular processes and physiological functions. ATP2B3 is involved in maintaining cellular calcium homeostasis, while CDC42BPB is a key regulator of actin cytoskeleton dynamics and cell migration. Both genes play critical roles in physiological processes and have been linked to diseases when their roles are disrupted. In addition to its distinctive clinical symptoms, CFCS can be distinguished from NS and CS by genetic testing. There are few published reports on CFCS due to the MAP2K1 gene pathogenic variant in China. In this report, we describe a patient who exhibited both classic and atypical symptoms of CFCS as a result of a pathogenic variant in the MAP2K1 gene. A two-year six-month-old boy was diagnosed with "slow growth in height and weight and developmental delay for more than two years". The child presented with a neurodevelopmental delay, an inability to sit independently, and no verbal communication; the child had a height of 78.6 cm (−3.7 SD) and weight of 8.34 kg (−3.9 SD) at the time of first visit. The child was born to a then 35-year-old G7P3 mom at the gestation age of 33 weeks and 4 days by a cesarian section due to premature rupture of membranes. The neonate measured 45 cm in length and weighed 2.35 kg. During pregnancy, fetal measurements showed that both the head and the abdomen circumferences were larger than normal for the gestational age, but no complications were seen in the neonatal period. The child was initially breastfed and introduced to complementary foods at s -Abstract Truncated-

Neonatal-onset Carbamoyl Phosphate Synthetase I Deficiency

Long-term Follow-Up of Children with Carbamoyl Phosphate Synthase 1 Deficiency Detected in Newborn Screening.

Neonatal-onset carbamoyl phosphate synthetaseⅠdeficiency:a case report and literature review

Two Novel CPS1 Mutations in a Case of Carbamoyl Phosphate Synthetase 1 Deficiency Causing Hyperammonemia and Leukodystrophy

Different Findings in Neonate Carbamyl-Phosphate Synthetase I Deficiency Disease

Two novel mutations in the CPS 1 gene of a newborn with carbamoyl phosphate synthetase 1 deficiency identified by next-generation sequencing

Carbamoyl phosphate synthetase 1 deficiency diagnosed by whole exome sequencing.

Novel Neonatal Variants of the Carbamoyl Phosphate Synthetase 1 Deficiency: Two Case Reports and Review of Literature

Carbamoly-phosphate synthetase 1 (CPS1) deficiency: A tertiary center retrospective cohort study and literature review

Detection of CPS1 gene mutation in a neonate with carbamoyl phosphate synthetaseⅠ deficiency

Molecular, biochemical, and clinical analyses of five patients with carbamoyl phosphate synthetase 1 deficiency

Clinical features and CPS1 variants in Chinese patients with carbamoyl phosphate synthetase 1 deficiency

A successful liver transplantation in a patient with neonatal-onset carbamoyl phosphate synthetase-1 deficiency

[Early Infantile Epileptic Encephalopathy Caused by PACS2 Gene Variation: Three Cases Report and Literature Review].

Congenital disorder of glycosylation type 1a:a case report

Neonate-onset Ornithine Transcarbamylase Deficiency

Carnitine palmitoyltransferase II (CPT II) deficiency responsible for refractory cardiac arrhythmias, acute multiorgan failure and early fatal outcome

Distinct neonatal hyperammonemia and liver synthesis dysfunction: case report of a severe MEGDHEL syndrome

Combined Oxidative Phosphorylation Deficiency Type-13 with Perinatal Presentation: A Case Report

A Case Report of Cardiofaciocutaneous Syndrome with MAP2K1 Pathogenic Variant

A Rare Case of Pontocerebellar Hypoplasia Type 1B With Literature Review